1. Home
  2. GNFT vs NUTX Comparison

GNFT vs NUTX Comparison

Compare GNFT & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • NUTX
  • Stock Information
  • Founded
  • GNFT 1999
  • NUTX 2011
  • Country
  • GNFT France
  • NUTX United States
  • Employees
  • GNFT N/A
  • NUTX N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • NUTX Retail: Computer Software & Peripheral Equipment
  • Sector
  • GNFT Health Care
  • NUTX Technology
  • Exchange
  • GNFT Nasdaq
  • NUTX Nasdaq
  • Market Cap
  • GNFT 179.7M
  • NUTX 182.2M
  • IPO Year
  • GNFT 2019
  • NUTX N/A
  • Fundamental
  • Price
  • GNFT $3.74
  • NUTX $49.00
  • Analyst Decision
  • GNFT Strong Buy
  • NUTX Strong Buy
  • Analyst Count
  • GNFT 1
  • NUTX 2
  • Target Price
  • GNFT $13.00
  • NUTX $55.00
  • AVG Volume (30 Days)
  • GNFT 9.9K
  • NUTX 36.9K
  • Earning Date
  • GNFT 09-19-2024
  • NUTX 03-27-2025
  • Dividend Yield
  • GNFT N/A
  • NUTX N/A
  • EPS Growth
  • GNFT N/A
  • NUTX N/A
  • EPS
  • GNFT 0.47
  • NUTX N/A
  • Revenue
  • GNFT $86,225,222.00
  • NUTX $292,000,390.00
  • Revenue This Year
  • GNFT $145.20
  • NUTX $25.00
  • Revenue Next Year
  • GNFT N/A
  • NUTX $14.40
  • P/E Ratio
  • GNFT $7.89
  • NUTX N/A
  • Revenue Growth
  • GNFT 175.45
  • NUTX 26.02
  • 52 Week Low
  • GNFT $3.35
  • NUTX $4.16
  • 52 Week High
  • GNFT $6.42
  • NUTX $49.75
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 49.41
  • NUTX 75.83
  • Support Level
  • GNFT $3.68
  • NUTX $36.05
  • Resistance Level
  • GNFT $4.03
  • NUTX $44.50
  • Average True Range (ATR)
  • GNFT 0.15
  • NUTX 3.71
  • MACD
  • GNFT 0.05
  • NUTX 1.22
  • Stochastic Oscillator
  • GNFT 57.35
  • NUTX 96.41

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Share on Social Networks: